Industry Leadership MVE Biological Solutions is a recognized leader in cryogenic storage and shipping devices, serving a broad customer base including biopharma, research institutions, and hospitals, indicating ongoing demand for high-quality, reliable low-temperature storage solutions.

Acquisition Synergies Since its acquisition by Cryoport in 2020, MVE has expanded its market reach and product integration opportunities, creating potential sales avenues through combined offerings in cryogenic logistics and storage technologies.

Award-Winning Innovation Receiving the ISBER Outstanding New Product Award demonstrates MVE’s commitment to innovative solutions, providing opportunities to position new or upgraded products to clients seeking cutting-edge cryogenic technology.

Growing Revenue With revenues estimated between 10 and 25 million dollars, MVE presents a solid financial profile with room for growth, making it a promising prospect for strategic partnership or sales expansion in cryogenic applications.

Industry Relevance Serving sectors like biopharma, gene therapies, and medical research places MVE at the forefront of biotechnological innovation, presenting opportunities to tailor solutions that support emerging trends in personalized medicine and biological research.